Klein T - Search Results

1

Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db/db diabetic mice.

Klimontov VV, Korbut AI, Taskaeva IS, Bgatova NP, Dashkin MV, Orlov NB, Khotskina AS, Zavyalov EL, Klein T. Klimontov VV, et al. Among authors: klein t. World J Diabetes. 2020 Dec 15;11(12):596-610. doi: 10.4239/wjd.v11.i12.596. World J Diabetes. 2020. PMID: 33384767 Free PMC article.

2

Long-term treatment with empagliflozin, a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats.

Thomas L, Grempler R, Eckhardt M, Himmelsbach F, Sauer A, Klein T, Eickelmann P, Mark M. Thomas L, et al. Among authors: klein t. Diabetes Obes Metab. 2012 Jan;14(1):94-6. doi: 10.1111/j.1463-1326.2011.01518.x. Epub 2011 Nov 13. Diabetes Obes Metab. 2012. PMID: 21985693

3

SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes.

Korbut AI, Taskaeva IS, Bgatova NP, Muraleva NA, Orlov NB, Dashkin MV, Khotskina AS, Zavyalov EL, Konenkov VI, Klein T, Klimontov VV. Korbut AI, et al. Among authors: klein t. Int J Mol Sci. 2020 Apr 23;21(8):2987. doi: 10.3390/ijms21082987. Int J Mol Sci. 2020. PMID: 32340263 Free PMC article.

4

Lung and Kidney ACE2 and TMPRSS2 in Renin-Angiotensin System Blocker-Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19.

Batchu SN, Kaur H, Yerra VG, Advani SL, Kabir MG, Liu Y, Klein T, Advani A. Batchu SN, et al. Among authors: klein t. Diabetes. 2021 Mar;70(3):759-771. doi: 10.2337/db20-0765. Epub 2020 Dec 11. Diabetes. 2021. PMID: 33310740

5

Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors.

Grempler R, Thomas L, Eckhardt M, Himmelsbach F, Sauer A, Sharp DE, Bakker RA, Mark M, Klein T, Eickelmann P. Grempler R, et al. Among authors: klein t. Diabetes Obes Metab. 2012 Jan;14(1):83-90. doi: 10.1111/j.1463-1326.2011.01517.x. Epub 2011 Nov 13. Diabetes Obes Metab. 2012. PMID: 21985634

6

Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus.

Luippold G, Klein T, Mark M, Grempler R. Luippold G, et al. Among authors: klein t. Diabetes Obes Metab. 2012 Jul;14(7):601-7. doi: 10.1111/j.1463-1326.2012.01569.x. Epub 2012 Feb 23. Diabetes Obes Metab. 2012. PMID: 22268612

7

Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet.

Vickers SP, Cheetham SC, Headland KR, Dickinson K, Grempler R, Mayoux E, Mark M, Klein T. Vickers SP, et al. Among authors: klein t. Diabetes Metab Syndr Obes. 2014 Jul 1;7:265-75. doi: 10.2147/DMSO.S58786. eCollection 2014. Diabetes Metab Syndr Obes. 2014. PMID: 25061325 Free PMC article.

8

The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin.

Kern M, Klöting N, Mark M, Mayoux E, Klein T, Blüher M. Kern M, et al. Among authors: klein t. Metabolism. 2016 Feb;65(2):114-23. doi: 10.1016/j.metabol.2015.10.010. Epub 2015 Nov 13. Metabolism. 2016. PMID: 26773934

9

Effects of Linagliptin on Pancreatic α Cells of Type 1 Diabetic Mice.

Zhang Y, Fava GE, Wu M, Htun W, Klein T, Fonseca VA, Wu H. Zhang Y, et al. Among authors: klein t. J Endocr Soc. 2017 Aug 31;1(10):1224-1234. doi: 10.1210/js.2017-00253. eCollection 2017 Oct 1. J Endocr Soc. 2017. PMID: 29264448 Free PMC article.

10

Influence of type-4 dipeptidyl peptidase inhibition on endothelium-dependent relaxation of aortae from a db/db mouse model of type 2 diabetes: a comparison with the effect of glimepiride.

Woodman OL, Ortega JM, Hart JL, Klein T, Potocnik S. Woodman OL, et al. Among authors: klein t. Diabetes Metab Syndr Obes. 2019 Aug 16;12:1449-1458. doi: 10.2147/DMSO.S215086. eCollection 2019. Diabetes Metab Syndr Obes. 2019. PMID: 31496778 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,063 results

Search Page